These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15833232)

  • 1. Clinical inquiries. Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction?
    Singh A; Blackwell J; Neher J
    J Fam Pract; 2005 Apr; 54(4):370-2. PubMed ID: 15833232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of diuretics in congestive heart failure: renal effects].
    Timio M; Saronio P; Venanzi S; Bellomo G; Timio F
    G Ital Nefrol; 2006; 23 Suppl 34():S44-6. PubMed ID: 16633994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical applications of intravenous diuretic therapy in decompensated heart failure.
    Cleland JG; Coletta A; Witte K
    Am J Med; 2006 Dec; 119(12 Suppl 1):S26-36. PubMed ID: 17113397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization.
    Abdel-Qadir HM; Tu JV; Yun L; Austin PC; Newton GE; Lee DS
    Am Heart J; 2010 Aug; 160(2):264-271.e1. PubMed ID: 20691831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats.
    Yoshida J; Yamamoto K; Mano T; Sakata Y; Nishio M; Ohtani T; Hori M; Miwa T; Masuyama T
    Cardiovasc Res; 2005 Oct; 68(1):118-27. PubMed ID: 16002057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do diuretics differ in terms of clinical outcome in congestive heart failure?
    Follath F
    Eur Heart J; 1998 Dec; 19 Suppl P():P5-8. PubMed ID: 9886706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
    Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J;
    Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction. II. Diuretics.
    Fortuna P; Reis I; Ascenção R; Carneiro AV
    Rev Port Cardiol; 2008; 27(7-8):977-89. PubMed ID: 18959094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unconventional treatment of severe heart failure in the elderly].
    Fidelman Z; Korshun Z
    Harefuah; 2000 Mar; 138(5):354-6, 424. PubMed ID: 10883130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
    J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and risks of furosemide in acute kidney injury.
    Ho KM; Power BM
    Anaesthesia; 2010 Mar; 65(3):283-93. PubMed ID: 20085566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diuretic in chronic cardiac failure: a clumsy partner].
    Rocca C
    Arch Mal Coeur Vaiss; 2006 Jun; 99(6):599-606. PubMed ID: 16878721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dyspnea and normal systolic function].
    Hasenfuss G; Hermann HP; Pieske B
    Herz; 2004 Sep; 29(6):602-8. PubMed ID: 15912435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiorenal syndrome].
    Portolés Pérez J; Cuevas Bou X
    Nefrologia; 2008; 28 Suppl 3():29-32. PubMed ID: 19018735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure in elderly patients.
    Spiecker M
    Exp Gerontol; 2006 May; 41(5):549-51. PubMed ID: 16621389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
    Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
    J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.